ES2164074T3 - Vacunas de virus de la hepatitis a. - Google Patents
Vacunas de virus de la hepatitis a.Info
- Publication number
- ES2164074T3 ES2164074T3 ES93921524T ES93921524T ES2164074T3 ES 2164074 T3 ES2164074 T3 ES 2164074T3 ES 93921524 T ES93921524 T ES 93921524T ES 93921524 T ES93921524 T ES 93921524T ES 2164074 T3 ES2164074 T3 ES 2164074T3
- Authority
- ES
- Spain
- Prior art keywords
- hav
- hepatitis virus
- virus vaccines
- mrc
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32421—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32432—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
UN VIRUS VIVO DE LA HEPATITIS A ADAPTADO PARA QUE CREZCA EN CELULAS MRC-5, CUYO VHA SE CARACTERIZA PREFERENTEMENTE POR UNA ATENUACION ADECUADA PARA LA ADMINISTRACION DE UNA VACUNA EFECTIVA A SERES HUMANOS Y ANIMALES SIN QUE SE PRODUZCA UNA INACTIVACION, METODOS PARA ADAPTAR EL VHA PARA QUE CREZCA EN LAS MCR-5, COMPOSICIONES DE VACUNAS Y METODO PARA VACUNAR A SERES HUMANOS CONTRA LA INFECCION PROVOCADA POR EL VHA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94733892A | 1992-09-18 | 1992-09-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2164074T3 true ES2164074T3 (es) | 2002-02-16 |
Family
ID=25485989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93921524T Expired - Lifetime ES2164074T3 (es) | 1992-09-18 | 1993-09-17 | Vacunas de virus de la hepatitis a. |
Country Status (14)
Country | Link |
---|---|
US (4) | US6180110B1 (es) |
EP (1) | EP0666751B1 (es) |
JP (1) | JP3523646B2 (es) |
AT (1) | ATE205536T1 (es) |
AU (1) | AU687012B2 (es) |
CA (1) | CA2144317C (es) |
DE (1) | DE69330758T2 (es) |
DK (1) | DK0666751T3 (es) |
ES (1) | ES2164074T3 (es) |
HK (1) | HK1013667A1 (es) |
NZ (1) | NZ256278A (es) |
PT (1) | PT666751E (es) |
SG (1) | SG73999A1 (es) |
WO (1) | WO1994006446A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP950097A2 (en) | 1994-03-08 | 1997-06-30 | Merck & Co Inc | Hepatitis a virus culture process |
CN1053590C (zh) * | 1998-10-19 | 2000-06-21 | 卫生部长春生物制品研究所 | 冻干甲型肝炎减毒活疫苗及其保护剂 |
US6368602B1 (en) * | 2000-06-16 | 2002-04-09 | Hadasit Medical Research Services And Development Ltd | Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine |
GB0304799D0 (en) | 2003-03-03 | 2003-04-09 | Glaxosmithkline Biolog Sa | Novel method |
US20050220734A1 (en) * | 2004-04-02 | 2005-10-06 | Allergan, Inc. | Therapy for melanin related afflictions |
WO2006007603A2 (en) * | 2004-07-13 | 2006-01-19 | Gen-Probe Incorporated | Compositions and methods for detection of hepatitis a virus nucleic acid |
US20100055670A1 (en) * | 2005-06-28 | 2010-03-04 | The Government of the US, Represented by the Secretary, Dept. of Health and Human Services | Growth of wild-type hepatitis a virus in cell culture |
WO2007134250A2 (en) * | 2006-05-12 | 2007-11-22 | Goldengate Software, Inc. | Method for forming homogeneous from heterogeneous data |
US9907746B2 (en) | 2009-07-06 | 2018-03-06 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
CA2767392C (en) | 2009-07-06 | 2017-03-14 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
CA2840079C (en) | 2010-07-06 | 2018-07-03 | Variation Biotechnologies Inc. | Compositions and methods for treating influenza |
CN102174477B (zh) * | 2010-12-28 | 2012-11-21 | 深圳康泰生物制品股份有限公司 | 甲型肝炎病毒株sh及其二倍体细胞适应方法 |
WO2012097346A1 (en) | 2011-01-13 | 2012-07-19 | Variation Biotechnologies, Inc. | Compositions and methods for treating viral infections |
US20140328876A1 (en) | 2011-11-18 | 2014-11-06 | Variation Biotechnologies Inc. | Synthetic derivatives of mpl and uses thereof |
EP2802353A4 (en) | 2012-01-12 | 2015-12-02 | Variation Biotechnologies Inc | COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS |
US20150079077A1 (en) | 2012-01-27 | 2015-03-19 | Variation Biotechnologies, Inc. | Methods and compositions for therapeutic agents |
KR102277089B1 (ko) | 2019-12-19 | 2021-07-14 | 에스케이바이오사이언스(주) | A형 간염 바이러스의 제조방법 및 상기의 방법에 따라 제조된 a형 간염 바이러스 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2398504A1 (fr) | 1977-07-29 | 1979-02-23 | Tours Inst Virologie | Culture de virus de l'hepatite a, in vitro. application a la production d'un antigene reactif, d'immunserums specifiques et de vaccins contre l'hepatite a |
US4894228A (en) * | 1982-04-07 | 1990-01-16 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against hepatitis A virus |
US4636469A (en) | 1982-04-07 | 1987-01-13 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Isolation of hepatitis A virus strain HM-175 |
US4620978A (en) | 1982-04-07 | 1986-11-04 | The United States Of America As Represented By The Department Of Health And Human Services | Hepatitis A virus purified and triply cloned |
US4532215A (en) | 1982-04-07 | 1985-07-30 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation of hepatitis A virus strain HM-175 |
US5516630A (en) | 1983-09-30 | 1996-05-14 | The United States Of America As Represented By The Department Of Health And Human Services | Methods of detecting hepatitis A virus |
US4783407A (en) * | 1985-09-30 | 1988-11-08 | Merck & Co., Inc. | Growth of hepatitus A virus in vero cells |
GB8800100D0 (en) | 1988-01-05 | 1988-02-10 | Almond J W | Attenuated viruses |
DE542949T1 (de) * | 1991-05-08 | 1993-09-02 | Schweiz. Serum- & Impfinstitut Bern, Bern, Ch | Hepatitis a virusstamm, verfahren zur isolierung eines hepatitis a virusstammes und vakzine hepatitis a. |
-
1993
- 1993-09-17 CA CA002144317A patent/CA2144317C/en not_active Expired - Lifetime
- 1993-09-17 ES ES93921524T patent/ES2164074T3/es not_active Expired - Lifetime
- 1993-09-17 WO PCT/US1993/008610 patent/WO1994006446A1/en active IP Right Grant
- 1993-09-17 JP JP50822594A patent/JP3523646B2/ja not_active Expired - Fee Related
- 1993-09-17 DK DK93921524T patent/DK0666751T3/da active
- 1993-09-17 PT PT93921524T patent/PT666751E/pt unknown
- 1993-09-17 AU AU48585/93A patent/AU687012B2/en not_active Ceased
- 1993-09-17 SG SG1996011170A patent/SG73999A1/en unknown
- 1993-09-17 EP EP93921524A patent/EP0666751B1/en not_active Expired - Lifetime
- 1993-09-17 NZ NZ256278A patent/NZ256278A/en not_active IP Right Cessation
- 1993-09-17 US US08/397,232 patent/US6180110B1/en not_active Expired - Lifetime
- 1993-09-17 AT AT93921524T patent/ATE205536T1/de active IP Right Revival
- 1993-09-17 DE DE69330758T patent/DE69330758T2/de not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/475,886 patent/US6113912A/en not_active Expired - Lifetime
-
1998
- 1998-12-23 HK HK98115009A patent/HK1013667A1/xx not_active IP Right Cessation
-
2000
- 2000-08-31 US US09/653,499 patent/US6423318B1/en not_active Expired - Fee Related
-
2002
- 2002-04-29 US US10/135,988 patent/US6680060B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP3523646B2 (ja) | 2004-04-26 |
WO1994006446A1 (en) | 1994-03-31 |
AU687012B2 (en) | 1998-02-19 |
CA2144317A1 (en) | 1994-03-31 |
PT666751E (pt) | 2002-01-30 |
SG73999A1 (en) | 2000-07-18 |
EP0666751A4 (en) | 1996-04-24 |
US6180110B1 (en) | 2001-01-30 |
CA2144317C (en) | 2004-08-03 |
ATE205536T1 (de) | 2001-09-15 |
US6423318B1 (en) | 2002-07-23 |
DE69330758D1 (de) | 2001-10-18 |
US20020176869A1 (en) | 2002-11-28 |
EP0666751B1 (en) | 2001-09-12 |
EP0666751A1 (en) | 1995-08-16 |
NZ256278A (en) | 1996-11-26 |
US6680060B2 (en) | 2004-01-20 |
JPH08504094A (ja) | 1996-05-07 |
US6113912A (en) | 2000-09-05 |
DK0666751T3 (da) | 2001-11-12 |
DE69330758T2 (de) | 2002-07-04 |
HK1013667A1 (en) | 1999-09-03 |
AU4858593A (en) | 1994-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2164074T3 (es) | Vacunas de virus de la hepatitis a. | |
NZ226332A (en) | Vaccine comprising transmissible gastroenteritis virus of swine for preventing canine coronavirus infection in dogs and process for preparation thereof | |
NO953091L (no) | Fremgangsmåte for dyrking av formerings- og respiratorisk syndromvirus fra gris og anvendelse derav i vaksiner | |
AU7763294A (en) | Live in ovo vaccine | |
US4556556A (en) | Vaccine for the prevention of vesicular stomatitis virus infection | |
US4400472A (en) | Novel rabies virus strain and a process for its preparation | |
DE3686158D1 (de) | Impfstoff gegen mastitis. | |
DE69633233D1 (de) | Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus | |
DE3853736D1 (de) | Staupevirus-Impfstoff. | |
AR009650A1 (es) | Mycoplasma synoviae atenuado vivo, su uso, un cultivo microbiologico que lo comprende, una vacuna bacteriana atenuada viva para la proteccion de las aves de corral contra la infeccion por mycoplasma synoviae y un metodo para preparar dicha vacuna. | |
HUP9700975A2 (hu) | Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok | |
DK0603386T3 (da) | Parenteral immunisering mod rotavirus | |
ES2066206T3 (es) | Utilizacion de adenilciclasa como vacunas contra bordetella. | |
Cho et al. | Protection of dogs against death from experimental rabies by postexposure administration of rabies vaccine and hyperimmune globulin (human). | |
EP0256792A3 (en) | Vaccines for fowl colibacillosis | |
RU94031386A (ru) | Вакцина сухая культуральная против вирусного энтерита гусей и способ профилактики и лечения вирусного энтерита гусей | |
RU94030087A (ru) | Способ получения вакцины против болезни гамборо | |
JPS56115724A (en) | Prophilaxis and remedy for avian infectious coryza | |
EP0178928A3 (en) | Vaccines | |
RO100317B1 (ro) | PROCEDEU DE OBTINERE A UNOR REACTIVI PENTRU STABILIREA TITRULUI DE ANTICORPI îN PSEUDOPESTA AVIARA | |
BG100932A (en) | Method for the preparation of cellular cultural inactivated vaccine against fowl pest | |
UA38343A (uk) | Спосіб моделювання асоційованої форми кандидо-герпетичної інфекції | |
KR870009018A (ko) | 단순 포진에 대한 왁진 | |
GB2129684A (en) | A process for the production of an inactivated adjuvated vaccine against Aujeszky disease | |
RU92011555A (ru) | Инактивированная вакцина против инфекционного ринотрахеита крупного рогатого скота |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 666751 Country of ref document: ES |